Working… Menu

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03544736
Recruitment Status : Active, not recruiting
First Posted : June 4, 2018
Last Update Posted : October 15, 2021
Bristol-Myers Squibb
Information provided by (Responsible Party):
Geir Olav Hjortland, Oslo University Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2025
Estimated Study Completion Date : December 31, 2040